Agency Forms Undergoing Paperwork Reduction Act Review, 68695-68696 [2022-24917]

Agencies

• Centers for Disease Control and Prevention
• DEPARTMENT OF HEALTH AND HUMAN SERVICES

[Federal Register Volume 87, Number 220 (Wednesday, November 16, 2022)]
[Notices]
[Pages 68695-68696]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-24917]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30Day-23-1233]


Agency Forms Undergoing Paperwork Reduction Act Review

    In accordance with the Paperwork Reduction Act of 1995, the Centers 
for Disease Control and Prevention (CDC) has submitted the information 
collection request titled ``Paul Coverdell National Acute Stroke 
Program (PCNASP) 2021-2024 Evaluation'' to the Office of Management and 
Budget (OMB) for review and approval. CDC previously published a 
``Proposed Data Collection Submitted for Public Comment and 
Recommendations'' notice on May 23, 2022 to obtain comments from the 
public and affected agencies. CDC did not receive comments related to 
the previous notice. This notice serves to allow an additional 30 days 
for public and affected agency comments.
    CDC will accept all comments for this proposed information 
collection project. The Office of Management and Budget is particularly 
interested in comments that:
    (a) Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
    (b) Evaluate the accuracy of the agencies estimate of the burden of 
the proposed collection of information, including the validity of the 
methodology and assumptions used;
    (c) Enhance the quality, utility, and clarity of the information to 
be collected;
    (d) Minimize the burden of the collection of information on those 
who are to respond, including, through the use of appropriate 
automated, electronic, mechanical, or other technological collection 
techniques or other forms of information technology, e.g., permitting 
electronic submission of responses; and
    (e) Assess information collection costs.
    To request additional information on the proposed project or to 
obtain a copy of the information collection plan and instruments, call 
(404) 639-7570. Comments and recommendations for the proposed 
information collection should be sent within 30 days of publication of 
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular 
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct 
written comments and/or suggestions regarding the items contained in 
this notice to the Attention: CDC Desk Officer, Office of Management 
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202) 
395-5806. Provide written comments within 30 days of notice 
publication.

Proposed Project

    Paul Coverdell National Acute Stroke Program (PCNASP) (DP21-2102) 
Evaluation (OMB Control No. 0920-1233)--Reinstatement with Change--
National Center for Chronic Disease Prevention and Health Promotion 
(NCCDPHP), Centers for Disease Control and Prevention (CDC).

Background and Brief Description

    The Centers for Disease Control and Prevention (CDC), Division for 
Heart Disease and Stroke Prevention (DHDSP), requests OMB approval for 
a Reinstatement of a previously approved data collection. The CDC is 
the primary federal agency for protecting health and promoting quality 
of life through the prevention and control of disease, injury, and 
disability. CDC is committed to programs that reduce the health and 
economic consequences of the leading causes of death and disability, 
thereby ensuring a long, productive, healthy life for all people.
    Stroke remains a leading cause of serious, long-term disability and 
is the fifth leading cause of death in the United States after heart 
disease, cancer, chronic lower respiratory diseases, and accidents. 
Estimates indicate that approximately 795,000 people suffer a first-
ever or recurrent stroke each year with more than 146,000 deaths 
annually. Although there have been significant advances in preventing 
and treating stroke, the rising prevalence of heart disease, diabetes, 
and obesity has increased the relative risk for stroke, especially in 
African American populations. Moreover, stroke's lifetime direct cost 
of health care and indirect cost of lost productivity is staggering and 
imposes a substantial societal economic burden. There is a critical 
need to improve access to and quality of care for those at highest risk 
for events and stroke patients among the continuum of care, 
particularly among high burden populations. Coverdell-funded state 
programs are in the forefront of developing and implementing system-
change efforts to improve stroke systems of care using strategies like 
linking and using data, using team based approaches to coordinate 
stroke care, and providing community resources to reach the

[[Page 68696]]

general populations and specifically those at highest risk of stroke 
events, and reduce disparities in access to quality care for high 
burden populations.
    When Congress directed CDC to establish the Paul Coverdell National 
Acute Stroke Program (PCNASP) in 2001, CDC intended to monitor trends 
in stroke and stroke care, with the ultimate mission of improving the 
quality of care for stroke patients in the United States. Since 2021, 
CDC has funded and provided technical assistance to 13 recipients to 
develop comprehensive stroke systems of care. A comprehensive system of 
care improves quality of care by creating seamless transitions for 
individuals experiencing stroke. In such a system, pre-hospital 
providers, in-hospital providers, and early post-hospital providers 
coordinate patient hand-offs and ensure continuity of care. While 
PCNASP has existed since 2001, the goal and mission of the program has 
evolved with each funding cycle. The 2021-2024 funding cycle is the 
first such initiative to focus on addressing health equity specifically 
and understanding efforts to impact stroke outcomes for those at 
highest risk of stroke. CDC contracted with RTI International to 
conduct a national evaluation to assess program implementation as well 
as short term and intermediate outcomes of the 13 funded recipients.
    CDC and RTI International propose to collect information from all 
PCNASP recipients to gain insight into the effectiveness of 
implementation approaches, including linking and using data, using 
team-based approaches to coordinate stroke care, and providing 
community resources in order to reach the general population and those 
at highest risk of stroke events, and reduce disparities in access to 
quality care for high burden populations. The information collection 
will focus on describing PCNASP specific contributions to effective 
state-based stroke systems of care and the costs associated with this 
work. Two components of the information collection include: (1) program 
implementation cost data collection from program recipients using a 
cost collection tool; and (2) interviews using Zoom, Skype, Teams or a 
similar technology with key program and partner staff. Cost data 
collection will focus on recipients' cumulative spending to support 
PCNASP activities, spending by reporting period, and spending 
associated with specific PCNASP strategies related to building 
comprehensive state-wide stroke systems of care and strategies focusing 
on high-risk populations. Interview questions will focus on how each 
recipient implemented its strategies to increase access to and quality 
of healthcare overall as well as for patients at highest risk of stroke 
events. The data collection will identify challenges encountered and 
how they were overcome, factors that facilitated implementation, 
lessons learned along the way, and observed outcomes and improvements. 
The information to be collected does not currently exist for large 
scale, statewide programs that employ multiple combinations of 
strategies to build comprehensive stroke systems of care. The insights 
to be gained from this data collection will be critical to improving 
immediate efforts and achieving the goals of spreading and replicating 
state-level strategies that are proven programmatically and are cost-
effective in contributing to a higher quality of care for stroke 
patients.
    OMB approval is requested for two years. The total estimated 
annualized burden hours are 117. There are no costs to the respondents 
other than their time to participate.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                     Number of    Average burden
          Type of respondents                   Form name            Number of     responses per   per response
                                                                    respondents     respondent      (in hours)
----------------------------------------------------------------------------------------------------------------
Program Manager.......................  Cost Collection Tool....              13               1               2
Program Director......................  Interviews using Zoom,                13               1               1
                                         Skype, Teams.
Quality Improvement Specialist........  Interviews using Zoom,                13               1               1
                                         Skype, Teams.
Partner Staff.........................  Interviews using Zoom,                52               1               1
                                         Skype, Teams.
----------------------------------------------------------------------------------------------------------------


Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific 
Integrity, Office of Science, Centers for Disease Control and 
Prevention.
[FR Doc. 2022-24917 Filed 11-15-22; 8:45 am]
BILLING CODE 4163-18-P